Panagora Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,668
Closed -$156K 1215
2023
Q4
$156K Sell
5,668
-11,963
-68% -$729K ﹤0.01% 1189
2023
Q3
$1.07M Buy
17,631
+1
+0% +$70 0.01% 764
2023
Q2
$1.16M Buy
17,630
+1,515
+9% +$111K 0.01% 733
2023
Q1
$1.02M Buy
16,115
+4,222
+35% +$482K 0.01% 827
2022
Q4
$1.65M Buy
11,893
+5,136
+76% +$724K 0.01% 694
2022
Q3
$855K Buy
+6,757
New +$764K 0.01% 927
2021
Q3
Sell
-296
Closed -$122K 1788
2021
Q2
$122K Hold
296
﹤0.01% 1822
2021
Q1
$115K Buy
+296
New +$146K ﹤0.01% 1935
2020
Q4
Sell
-172
Closed -$120K 2813
2020
Q3
$120K Hold
172
﹤0.01% 1732
2020
Q2
$136K Hold
172
﹤0.01% 1687
2020
Q1
$102K Hold
172
﹤0.01% 1691
2019
Q4
$195K Hold
172
﹤0.01% 1614
2019
Q3
$204K Hold
172
﹤0.01% 1623
2019
Q2
$283K Hold
172
﹤0.01% 1659
2019
Q1
$350K Hold
172
﹤0.01% 1523
2018
Q4
$221K Hold
172
﹤0.01% 1590
2018
Q3
$325K Hold
172
﹤0.01% 1505
2018
Q2
$350K Sell
172
-705
-80% -$1.61M ﹤0.01% 1478
2018
Q1
$1.94M Buy
877
+705
+410% +$1.79M 0.01% 886
2017
Q4
$397K Hold
172
﹤0.01% 1441
2017
Q3
$306K Hold
172
﹤0.01% 1520
2017
Q2
$234K Hold
172
﹤0.01% 1595
2017
Q1
$202K Hold
172
﹤0.01% 1654
2016
Q4
$137K Sell
172
-2,037
-92% -$1.62M ﹤0.01% 1857
2016
Q3
$1.94M Buy
2,209
+2,037
+1,184% +$1.48M 0.01% 917
2016
Q2
$96K Sell
172
-118
-41% -$66.8K ﹤0.01% 1924
2016
Q1
$160K Buy
290
+172
+146% +$106K ﹤0.01% 1732
2015
Q4
$98K Hold
118
﹤0.01% 1804
2015
Q3
$131K Sell
118
-129
-52% -$235K ﹤0.01% 1737
2015
Q2
$539K Buy
247
+187
+312% +$381K ﹤0.01% 1306
2015
Q1
$94K Buy
+60
New +$79.2K ﹤0.01% 1954
2013
Q4
Sell
-2,509
Closed -$876K 2174
2013
Q3
$876K Buy
+2,509
New +$932K ﹤0.01% 1155

Other funds holding BLUE

Panagora Asset Management's BLUE Position: Q1 2024 in Review

Panagora Asset Management sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 5,668 shares — an estimated $156K sold.

Panagora Asset Management first reported a position in BLUE in Q3 2013 and held it in 32 quarters. The position peaked at $1.94M in Q1 2018. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Panagora Asset Management reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Panagora Asset Management sold 5,668 bluebird bio shares in Q1 2024, an estimated $156K.
  • Panagora Asset Management first reported a position in bluebird bio in Q3 2013 and held it in 32 quarters.
  • Panagora Asset Management's bluebird bio position peaked at $1.94M in Q1 2018.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Panagora Asset Management's 13F filing for Q1 2024, filed 7 May 2024.